May 5, 2015 – FDA warns of an increased risk of diabetic ketoacidosis with SGLT2 inhibitor diabetes drugs.
May 5, 2015 – FDA warns of an increased risk of diabetic ketoacidosis with SGLT2 inhibitor diabetes drugs.